What’s the difference between an extrovert and introvert in the world of principal investigators? Answer: Are they staring at your shoes or their shoes? The joke Steve Blank told during a fireside chat hosted by NYCBio illustrates the uphill challenge SBIR grant applicants face when they’re asked to break away from the insulated world of […]
Steve Blank, a serial entrepreneur, author and professor at Stanford University, developed the curriculum for the National Science foundation’s business boot camp for scientists before the NIH adopted it for scientists in the SBIR grant program. At a fireside chat at New York University Langone Medical Center hosted by NYC Bio this week, Blank talked […]
When customer development and the Lean Startup were just a sketch on the napkin, Dino Vendetti, a VC at Bay Partners, was one of the first venture capitalists I shared my ideas with. Dino and I kept in touch as he moved up to Bend, Ore., on a mission to engineer Bend into a regional […]
Dino Vendetti a VC at Bay Partners, moved to Bend, Oregon, on a mission to engineer Bend into a regional technology cluster. Over the years, Dino and I brainstormed about how Lean entrepreneurship would affect regional development. I visited Bend last year and caught up with his progress. Today with every city, state, and country […]
This post is part of our series on the National Science Foundation I-Corps Lean LaunchPad class in Life Science and Health Care at UCSF. Doctors, researchers and Principal Investigators in this class got out of the lab and hospital talked to 2,355 customers, tested 947 hypotheses and invalidated 423 of them. The class had 1,145 engagements with instructors […]
This post is part of our series on the National Science Foundation I-Corps Lean LaunchPad class in Life Science and Health Care at UCSF. Doctors, researchers and Principal Investigators in this class got out of the lab and hospital talked to 2,355 customers, tested 947 hypotheses and invalidated 423 of them. The class had 1,145 engagements with instructors […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Steve Blank has faced the challenge of healthcare startups and found a solution. First he taught the Lean LaunchPad class to the National Science Foundation Innovation Corps for two and a half years. As he has immersed himself in healthcare and its challenges, he has pinpointed the problem with most tech transfer offices. “Life science […]
If you are a proud new life sciences startup owner, founder, employee or, hey, even that guy tinkering with an idea in his basement, you need to be reading Steve Blank‘s “Reinventing Life Science Startups” series on LinkedIn. Blank has been part of eight Silicon Valley startups, teaches entrepreneurship at several universities and is a board […]
